Find and Pitch Jounalists, Get Your Story Covered

Tags: MDMA ecstasy PTSD therapy care continuum communication

	Profile	Recent Articles on Subject
1	Ed Silverman STAT News Pharmalot columnist. Senior writer at STATnews. pharmaceutical industry	STAT+: Two generic drugmakers to pay $49 million to settle price-fixing charges - 12 days ago STAT+: Sales from controversial drug discount program rose to $63 billion last year - 25 days ago STAT+: Pharmalittle: We’re reading about FTC scrutiny of a Novo deal, a Genentech reorganization, and more - 3 months ago STAT+: Pharmalittle: We’re reading about AbbVie spending on doctors, a new Lilly deal, and more - 4 months ago STAT+: Pharmalittle: We’re reading about drug shortages, Medicare spending on an Alzheimer’s drug, and more - 7 months ago STAT+: Pharmalittle: We’re reading about a Lilly obesity-drug ad, a $35 cap on inhalers, and more - 8 months ago STAT+: Pharmalittle: We’re reading about a nixed Medicare negotiation lawsuit, an Obamacare challenge, and more - 8 months ago STAT+: Many costly generic drugs are unavailable at Amazon, Cuban, and other alternative pharmacies - 9 months ago STAT+: Pharmalittle: We’re reading about state moves on drug pricing, an asthma med for kids and more - 9 months ago STAT+: Pharmalittle: We’re reading about drug price hikes, Bayer strategic moves, and more - 10 months ago STAT+: Pharmalittle: Drugmakers raise prices, pharmacies fear fees, McKinsey settles - 11 months ago STAT+: Pharmalittle: U.S. to impose inflation penalties on dozens of drugmakers; Supreme Court will decide abortion pill access - 11 months ago STAT+: The prices of 8 drugs were hiked without proof of new benefits, costing the U.S. $1.2 billion in 2022, report finds - 11 months ago STAT+: Pharmalittle: White House takes aim at pharma patents to lower drug prices; Sanofi CEO defends reducing earnings forecast - 11 months ago STAT+: Pharmalittle: CVS to overhaul how it’s paid for drugs; Biden drug-shortage plan won’t expand chemo supplies - 11 months ago STAT+: Pharmalittle: U.S. Senate eyes more policies for regulating PBMs; Novo claims most U.S. Wegovy patients pay less than $25 a month - about 1 year ago STAT+: Health plan formularies lowered barriers to fair access to some drugs, analysis finds - about 1 year ago STAT+: Medicare is urged to consider Amgen patent maneuvers when negotiating the price for a drug - about 1 year ago STAT+: Pharmalittle: Pharma moves closer to a pricing deal with U.K.; FDA to review AstraZeneca request for self-administered flu vax - about 1 year ago STAT+: Pharmalittle: Pfizer prices Paxlovid at $1,400 for a five-day course; EMA warns of counterfeit Ozempic - about 1 year ago STAT+: Medicare may plan to negotiate drug prices, but some states are taking their own steps to lower costs - about 1 year ago STAT+: Pharmalittle: U.S. Chamber and feds clash on Medicare price negotiation; South Africa probes J&J over TB-drug pricing - about 1 year ago
2	Emily Olsen Healthcare Dive Reporter at Healthcare Dive. Loyola, Medill alum. Chicago, Illinois HealthcareNews	Texas sues major PBMs, pharma companies over high insulin prices - about 1 month ago
3	John Wilkerson STAT News STAT Washington correspondent. Healthcare Journalism	STAT+: Higher insurance costs eat into savings from drug pricing law by more than expected - about 1 month ago STAT+: Venture capital is still pouring into drug research despite Medicare price negotiation - 11 months ago STAT+: Hearing on Medicare drug price negotiation gets unusually heated - about 1 year ago
4	Meagan Parrish Pharma Voice Senior editor @industrydive. Pharma world follower. Wisconsin, USA pharmaceuticalsjournalismparenting	Is anyone taking the world’s priciest drugs? - 2 months ago
5	Rebecca Pifer Healthcare Dive Reporter @healthcaredive. New York City, United States insurancedigital health	Large employers forecast 7.8% hike in health costs next year, thanks to rising pharmacy spend - 3 months ago CVS overhauls how its retail pharmacies charge for prescription drugs - 11 months ago Optum Rx moves 8 insulins to preferred formulary status as pressure mounts on PBMs - about 1 year ago
6	Joyce Frieden MedPage Today Washington editor at MedPage Today. Board member at AHCJ. Greater Washington, DC area Healthcare journalism	Is Medicare's Negotiated Drug Price List Worth Celebrating? Depends on Whom You Ask. - 3 months ago Biden Administration Announces Moves to Cut Drug Prices - 11 months ago States Making Progress Toward Setting Payment Limits for Some Drugs - 12 months ago
7	Jonathan Gardner Healthcare Dive Senior reporter. BioPharma Dive. Charlottesville, Virginia BiopharmaceuticalsJournalism	Medicare drug price cuts could have limited early impact, but grow with time - 3 months ago Biden administration goes after drug patents in bid to lower prices - 11 months ago
8	Amy Baxter Pharma Voice Scientist, inventor, former pediatrician. Atlanta, Georgia pain relieftechnologyinnovation	The drugs hit hardest by Medicare price negotiations - 3 months ago Pharma execs react to final drug price negotiations with Medicare - 3 months ago 3 Big Pharma cancer drugs facing inflation penalties - 3 months ago The IRA will lower U.S. drug spending, CMS finds — but not for awhile - 4 months ago Cutting pills. Rationing insulin. How Americans struggle to pay for drugs. - 7 months ago Could pharma’s legal attack on the IRA succeed in killing price negotiations? - 8 months ago
9	Frank Vinluan MedCity News Medical innovation tracker. MedCity, USA medicalinnovation	CMS Touts First Negotiated Drug Prices, But Greater Impact Expected in Future Rounds - 3 months ago
10	Beth Mole Ars Technica Senior Health Reporter @ArsTechnica. microbiologyinfectious diseasespublic health	Medicare drug price negotiations: 10 list prices drop between 38% to 79% - 3 months ago Big Pharma’s fight against drug price reforms takes weird, desperate turn - 5 months ago Big Pharma fought drug pricing reform with record $7.5M dark money donation - 12 months ago

Journalists covering Drug prices